|  Help  |  About  |  Contact Us

Publication : Increasing nitric oxide bioavailability fails to improve collateral vessel formation in humanized sickle cell mice.

First Author  Lewis CV Year  2022
Journal  Lab Invest Volume  102
Issue  8 Pages  805-813
PubMed ID  35354915 Mgi Jnum  J:354921
Mgi Id  MGI:7736871 Doi  10.1038/s41374-022-00780-0
Citation  Lewis CV, et al. (2022) Increasing nitric oxide bioavailability fails to improve collateral vessel formation in humanized sickle cell mice. Lab Invest 102(8):805-813
abstractText  Sickle cell disease (SCD) is associated with repeated bouts of vascular insufficiency leading to organ dysfunction. Deficits in revascularization following vascular injury are evident in SCD patients and animal models. We aimed to elucidate whether enhancing nitric oxide bioavailability in SCD mice improves outcomes in a model of vascular insufficiency. Townes AA (wild type) and SS (sickle cell) mice were treated with either L-Arginine (5% in drinking water), L-NAME (N(omega)-nitro-L-arginine methyl ester; 1 g/L in drinking water) or NO-generating hydrogel (PA-YK-NO), then subjected to hindlimb ischemia via femoral artery ligation and excision. Perfusion recovery was monitored over 28 days via LASER Doppler perfusion imaging. Consistent with previous findings, perfusion was impaired in SS mice (63 +/- 4% of non-ischemic limb perfusion in AA vs 33 +/- 3% in SS; day 28; P < 0.001; n = 5-7) and associated with increased necrosis. L-Arginine treatment had no significant effect on perfusion recovery or necrosis (n = 5-7). PA-YK-NO treatment led to worsened perfusion recovery (19 +/- 3 vs. 32 +/- 3 in vehicle-treated mice; day 7; P < 0.05; n = 4-5), increased necrosis score (P < 0.05, n = 4-5) and a 46% increase in hindlimb peroxynitrite (P = 0.055, n = 4-5). Interestingly, L-NAME worsened outcomes in SS mice with decreased in vivo lectin staining following ischemia (7 +/- 2% area in untreated vs 4 +/- 2% in treated mice, P < 0.05, n = 5). Our findings demonstrate that L-arginine and direct NO delivery both fail to improve postischemic neovascularization in SCD. Addition of NO to the inflammatory, oxidative environment in SCD may result in further oxidative stress and limit recovery.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

7 Bio Entities

Trail: Publication

0 Expression